Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 发起方
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- To evaluate the growth of endometrial thickness
研究概览
简要总结
Women in assisted reproduction treatment they receive own or donated embryos and presenting an endometrial development less than 5 mm despite having received treatment with estrogen therapy knowing the clinical value of using the PRGF-Endoret therapy and endometrial level applications to improve endometrial thickness endometrial preparations for embryo transfer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 49 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.
- •Less than 5mm despite 10 days with standard doses of estrogen therapy (6mg / 24h) Endometrio
排除标准
- •History of pelvic inflammatory disease
- •Risk of infection
研究组 & 干预措施
Endometrium with less than 5mm
Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.
Less than 5mm despite 10 days with standard doses of estrogen
干预措施: Growth Factor, Platelet-Derived (Drug)
结局指标
主要结局
To evaluate the growth of endometrial thickness
时间窗: During ovarian stimulation protocol 8-12 days
The endometrial thickness will be measured by vaginal ultrasound. Endometrium less than 5 mm will be treated
次要结局
- Analyze the impact of using platelet plasma on rates of implantation and pregnancy.(During ovarian stimulation protocol 8-12 days)